Casein Kinase II Subunit Alpha (CSNK2A2) as a Drug Target and Biomarker

Target Name: CSNK2A2

NCBI ID: G1459

CSNK2A2

Casein Kinase II Subunit Alpha (CSNK2A2) as a Drug Target and Biomarker

Introduction

Casein kinase II subunit alpha (CSNK2A2) is a protein that plays a critical role in various cellular processes, including cell signaling, DNA replication, and apoptosis. It is a member of the casein kinase II family, which is known for their role in regulating cellular processes that are essential for cell survival and growth. In this article, we will discuss CSNK2A2 as a drug target and biomarker, and its potential clinical applications.

Drug Target and Biomarker

CSNK2A2 is a protein that can be targeted by small molecules, making it an attractive drug candidate for the treatment of various diseases. One of the key challenges in developing new treatments for diseases is identifying the underlying molecular mechanisms that drive the disease. In the case of CSNK2A2, its role in cell signaling and apoptosis makes it an attractive target for drug development.

One of the key functions of CSNK2A2 is its role in the regulation of cell apoptosis. Apoptosis is a natural process that is essential for the development and maintenance of tissues and organs. However, when cells are damaged or undergo certain stressors, they can undergo apoptosis to remove damaged or dysfunctional cells, allowing the body to repair and regenerate.

CSNK2A2 plays a critical role in the regulation of apoptosis by promoting the production of activating transcription factor-3 (ATF-3). ATF-3 is a transcription factor that plays a critical role in the regulation of apoptosis, as it promotes the production of pro-apoptotic proteins that can trigger the death of cells. CSNK2A2 can also inhibit the production of anti-apoptotic proteins, which can protect cells from death.

In addition to its role in apoptosis, CSNK2A2 is also involved in the regulation of cell signaling. It is a key regulator of the T-cell receptor (TCR), which is responsible for cell survival and growth. CSNK2A2 has been shown to play a critical role in the regulation of TCR function, by promoting the activation and proliferation of T-cells, and by inhibiting their apoptosis.

CSNK2A2 has also been shown to play a critical role in the regulation of DNA replication. It is a regulator of the Ku70 gene, which is involved in the regulation of DNA replication. Ku70 is a non-coding RNA molecule that plays a critical role in the regulation of DNA replication, by promoting the production of Ku70 RNA, which can interact with the DNA template to ensure accurate replication of the genetic material.

CSNK2A2 is also involved in the regulation of cell signaling, specifically in the regulation of the production of pro-inflammatory cytokines. It is a key regulator of the transcription factor-9 (TF-9), which is involved in the production of pro- inflammatory cytokines, such as TNF-alpha, IL-1, and IL-6. CSNK2A2 has been shown to play a critical role in the regulation of TF-9 production, by promoting the production of TF-9 RNA, and by inhibiting the production of anti-TF-9 RNA.

Conclusion

In conclusion, CSNK2A2 is a protein that plays a critical role in various cellular processes, including cell signaling, DNA replication, and apoptosis. Its role in these processes makes it an attractive target for drug development, particularly for the treatment of diseases that are characterized by dysfunctional cellular processes. As a drug target and biomarker, CSNK2A2 has the potential to revolutionize the treatment of a variety of diseases.

Protein Name: Casein Kinase 2 Alpha 2

Functions: Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. During viral infection, phosphorylates various proteins involved in the viral life cycles of EBV, HSV, HBV, HCV, HIV, CMV and HPV

The "CSNK2A2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CSNK2A2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets